Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Immunohistochemically, canine hemangiosarcomas were strongly positive using commercially provided anti human MUC1 antibody. In canine hemangiosarcoma cell lines, lesser molecular weight band (22kDa) was detected with Western blotting. Peptide sequencing after immunoprecipitation with the antibody revealed the antigen was canine peroxiredoxin 6(Prdx6). Apoptosis was induced in canine hemangiosarcoma cell lines by Prdx6 knockdown with small interfering RNA method. uPA/uPAR, which associating with Prdx6 in malignant proliferation and invasion, were strongly positive in canine hemangiosarcomas. In conclusion, Prdx6 and uPA/uPAR may associate with in malignant proliferation of canine hemangiosarcomas.
|